The rising prevalence of Alzheimer’s disease, an expanding aging population, and growing awareness of cognitive health are driving demand for advanced diagnostic and therapeutic solutions in the United States. Healthcare providers are increasingly emphasizing early detection, continuous disease monitoring, and timely treatment to improve patient outcomes. Advances in biomarker-based...